FunPep Company Limited
Tokyo Stock Exchange 4881.T
FunPep Company Limited Net Income for the year ending December 31, 2023: USD -6.62 M
-
FunPep Company Limited Net Income for the year ending December 31, 2022 was USD -8.94 M, a -50.84% change year over year.
-
FunPep Company Limited Net Income for the year ending December 31, 2021 was USD -5.93 M, a -20.57% change year over year.
-
FunPep Company Limited Net Income for the year ending December 31, 2020 was USD -4.92 M, a -127.17% change year over year.
-
FunPep Company Limited Net Income for the year ending December 31, 2019 was USD -2.16 M.
| Date | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) | Net Income Margin |
|---|
| CEO | Mr. Toshimi Miyoshi Ph.D., Pharm.D. |
| IPO Date | Dec. 25, 2020 |
| Location | Japan |
| Headquarters | No.7 Mizuho Building |
| Employees | 15 |
| Sector | Health Care |
| Industries | |
FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides. The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis. It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis. FunPep Company Limited was incorporated in 2013 and is based in Tokyo, Japan.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email